BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15281461)

  • 1. [Immunostimulatory sequence and DNA vaccine].
    Zhao S; Zhu YC
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Apr; 22(2):122-5. PubMed ID: 15281461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enhancement of the protective effect of SjC23 DNA vaccine against Schistosoma japonicum infection by immunostimulatory sequence].
    Zhao S; Zhu YC; Harn DA; Si J; Ren JG; Yin XR; He W; Liang YS; Xu M; Xu YL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 16042196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulatory DNA as a vaccine adjuvant.
    Higgins D; Marshall JD; Traquina P; Van Nest G; Livingston BD
    Expert Rev Vaccines; 2007 Oct; 6(5):747-59. PubMed ID: 17931155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant activity of CpG oligodeoxynucleotides.
    Klinman DM
    Int Rev Immunol; 2006; 25(3-4):135-54. PubMed ID: 16818369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides.
    Wu W; Weigand L; Belkaid Y; Mendez S
    Eur J Immunol; 2006 Dec; 36(12):3238-47. PubMed ID: 17109471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress of research on DNA vaccines against parasitosis].
    Qi WJ; Fang Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):340-4. PubMed ID: 22164511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy.
    Kennedy NJ; Spithill TW; Tennent J; Wood PR; Piedrafita D
    Vaccine; 2006 Feb; 24(7):970-9. PubMed ID: 16242220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MPT-51/CpG DNA vaccine protects mice against Mycobacterium tuberculosis.
    Silva BD; da Silva EB; do Nascimento IP; Dos Reis MC; Kipnis A; Junqueira-Kipnis AP
    Vaccine; 2009 Jul; 27(33):4402-7. PubMed ID: 19500525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sperm DNA vaccine on fertility of female mice.
    Naz RK
    Mol Reprod Dev; 2006 Jul; 73(7):918-28. PubMed ID: 16596628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy.
    Chaung HC
    Int Immunopharmacol; 2006 Oct; 6(10):1586-96. PubMed ID: 16919831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs?
    Verfaillie T; Cox E; Goddeeris BM
    Vet Immunol Immunopathol; 2005 Jan; 103(1-2):141-51. PubMed ID: 15626469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro assay of immunostimulatory activities of plasmid vectors.
    Jiang W; Reich CF; Pisetsky DS
    Methods Mol Med; 2006; 127():55-70. PubMed ID: 16988446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.
    Babiuk S; Mookherjee N; Pontarollo R; Griebel P; van Drunen Littel-van den Hurk S; Hecker R; Babiuk L
    Immunology; 2004 Sep; 113(1):114-20. PubMed ID: 15312142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA.
    Lee KW; Jung J; Lee Y; Kim TY; Choi SY; Park J; Kim DS; Kwon HJ
    Mol Immunol; 2006 May; 43(13):2107-18. PubMed ID: 16442622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties.
    Bianco A; Hoebeke J; Godefroy S; Chaloin O; Pantarotto D; Briand JP; Muller S; Prato M; Partidos CD
    J Am Chem Soc; 2005 Jan; 127(1):58-9. PubMed ID: 15631447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice.
    Tengvall S; Josefsson A; Holmgren J; Harandi AM
    J Reprod Immunol; 2005 Dec; 68(1-2):53-69. PubMed ID: 16229896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune effects and mechanisms of action of CpG motifs.
    Krieg AM
    Vaccine; 2000 Nov; 19(6):618-22. PubMed ID: 11090712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Mol Immunol; 2007 Feb; 44(6):1141-9. PubMed ID: 16911828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG DNA: a novel immunomodulator.
    Krieg AM
    Trends Microbiol; 1999 Feb; 7(2):64-5. PubMed ID: 10081082
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA vaccines: capacity to induce auto-immunity and tolerance.
    Klinman DM; Takeshita F; Kamstrup S; Takeshita S; Ishii K; Ichino M; Yamada H
    Dev Biol (Basel); 2000; 104():45-51. PubMed ID: 11713823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.